ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site

被引:106
作者
Adriouch, Sahil [1 ,3 ]
Bannas, Peter [1 ]
Schwarz, Nicole [1 ]
Fliegert, Ralf [2 ]
Guse, Andreas H. [2 ]
Seman, Michel [3 ]
Haag, Friedrich [1 ]
Koch-Nolte, Friedrich [1 ]
机构
[1] Univ Hamburg, Hosp Eppendorf, Ctr Diagnost, Inst Immunol, D-20246 Hamburg, Germany
[2] Univ Hamburg, Hosp Eppendorf, Inst Biochem & Mol Biol 1, D-20246 Hamburg, Germany
[3] Univ Rouen, Fac Med & Pharm, INSERM, U 519, Rouen, France
关键词
post-translational modification; purinoceptors; ADP-ribosyltransferases; leukocyte ecto-enzymes;
D O I
10.1096/fj.07-9294com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ADP-ribosylation is a post-translational modification regulating protein function in which amino acid-specific ADP-ribosyltransferases (ARTs) transfer ADP-ribose from NAD onto specific target proteins. Attachment of the bulky ADP-ribose usually inactivates the target by sterically blocking its interaction with other proteins. P2X7, an ATP-gated ion channel with important roles in inflammation and cell death, in contrast, is activated by ADP-ribosylation. Here, we report the structural basis for this gating and present the first molecular model for the activation of a target protein by ADP-ribosylation. We demonstrate that the ecto-enzyme ART2.2 ADP-ribosylates P2X7 at arginine 125 in a prominent, cysteine-rich region at the interface of 2 receptor subunits. ADP-ribose shares an adenine-ribonculeotide moiety with ATP. Our results indicate that ADP-ribosylation of R125 positions this common chemical framework to fit into the nucleotide-binding site of P2X7 and thereby gates the channel.
引用
收藏
页码:861 / 869
页数:9
相关论文
共 53 条
[1]   Probing the expression and function of the P2X7 purinoceptor with antibodies raised by genetic immunization [J].
Adriouch, S ;
Dubberke, G ;
Diessenbacher, P ;
Rassendren, FO ;
Seman, M ;
Haag, F ;
Koch-Nolte, F .
CELLULAR IMMUNOLOGY, 2005, 236 (1-2) :72-77
[2]   Cutting edge: A natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor [J].
Adriouch, S ;
Dox, C ;
Welge, V ;
Seman, M ;
Koch-Nolte, F ;
Haag, F .
JOURNAL OF IMMUNOLOGY, 2002, 169 (08) :4108-4112
[3]   BOTULINUM-C2 TOXIN ADP-RIBOSYLATES ACTIN [J].
AKTORIES, K ;
BARMANN, M ;
OHISHI, I ;
TSUYAMA, S ;
JAKOBS, KH ;
HABERMANN, E .
NATURE, 1986, 322 (6077) :390-392
[4]  
AKTORIES K, 2000, BACTERIAL PROTEIN TO
[5]   Activity and specificity of toxin-related mouse T cell ecto-ADP-ribosyltransferase ART2.2 depends on its association with lipid rafts [J].
Bannas, P ;
Adriouch, S ;
Kahl, S ;
Braasch, F ;
Haag, F ;
Koch-Nolte, F .
BLOOD, 2005, 105 (09) :3663-3670
[6]   A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes [J].
Cabrini, G ;
Falzoni, S ;
Forchap, SL ;
Pellegatti, P ;
Balboni, A ;
Agostini, P ;
Cuneo, A ;
Castoldi, G ;
Baricordi, OR ;
Di Virgilio, F .
JOURNAL OF IMMUNOLOGY, 2005, 175 (01) :82-89
[7]   Mutational analysis of the conserved cysteines of the rat P2X2 purinoceptor [J].
Clyne, JD ;
Wang, LF ;
Hume, RI .
JOURNAL OF NEUROSCIENCE, 2002, 22 (10) :3873-3880
[8]   Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century [J].
Collier, RJ .
TOXICON, 2001, 39 (11) :1793-1803
[9]   Functional aspects of protein mono-ADP-ribosylation [J].
Corda, D ;
Di Girolamo, M .
EMBO JOURNAL, 2003, 22 (09) :1953-1958
[10]   Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation [J].
Coutinho-Silva, R ;
Stahl, L ;
Raymond, MN ;
Jungas, T ;
Verbeke, P ;
Burnstock, G ;
Darville, T ;
Ojcius, DM .
IMMUNITY, 2003, 19 (03) :403-412